|
US2020308306A1
|
|
Immunoassay for mitragynine
|
|
US2017088892A1
|
|
Formalin Fixed Paraffin Embedded (FFPE) Control Reagents
|
|
US2016025753A1
|
|
Assay for cannabinoids and methods of use thereof
|
|
US2011003314A1
|
|
Hapten, Immunogens and Derivatives of Ascomycin Useful for Preparation of Antibodies and Immunoassays
|
|
US2006035297A1
|
|
Reagents and methods for mycophenolic acid immunoassay
|
|
EP1530189A2
|
|
Multiple product, multiple language package insert
|
|
GB0105517D0
|
|
Ecstasy-class analogs and use of same in detection of ecstasy-class compounds
|
|
US6262265B1
|
|
Non-hydrolyzable analogs of heroin metabolites suitable for use in immunoassay
|
|
AU2775299A
|
|
Immunoassays for determination of lsd and lsd metabolites
|
|
US6306616B1
|
|
Adsorption type confirmatory assays
|
|
EP1066523A2
|
|
Confirmatory assays for small molecule drugs
|
|
US6207396B1
|
|
Immunoassay reagents and methods for determination of LSD and LSD metabolites
|
|
US5573955A
|
|
Reducing tyramine interference in immunoassays for amphetamine and methamphetamine
|
|
US5604091A
|
|
Methods for protein binding enzyme complementation
|
|
CA2068190A1
|
|
Methods and compositions for enzyme complementation assays using the omega region of beta-galactosidase
|
|
US5188938A
|
|
Enzyme quantitation wicking assay
|
|
US5244785A
|
|
Determination of high molecular weight analytes using a β-galactosidase complementation assay
|
|
EP0419081A2
|
|
Method for protein binding enzyme complementation assays
|
|
US5244786A
|
|
Method of measuring available free thyroxine bending sites
|
|
US5223393A
|
|
Detection of analytes having binding sites for at least two binding moieties
|
